title: Effects of Bacillus subtilis var. natto products on symptoms caused by blood flow disturbance in female patients with lifestyle diseases.
abstract: The fermented soybean product natto is a popular traditional food in Japan and is considered a health supplement. NKCP(®), a natto-derived dietary food supplement whose main component is bacillopeptidase F, has antithrombotic, fibrinolytic, and blood pressure-lowering effects. We examined whether daily intake of NKCP(®) effectively improves subjective symptoms in patients with lifestyle diseases in this cross-over, double-blind study. Fermented soya extract with subtilisin NAT (nattokinase) as the main component was used as an active placebo. A 4-week course of NKCP(®) significantly decreased the visual analog scale (VAS) score for shoulder stiffness from 42.3 to 32.4 (P=0.009), the VAS score for low back pain from 25.5 to 18.8 (P=0.02), and the VAS score for coldness of the extremities from 33.1 to 25.7 (P=0.002). However, no significant difference was found in the VAS score for headache. After a 4-week course of active placebo, no significant changes in the VAS score were found for any symptoms. The significant improvement in the symptoms secondary to blood flow disturbance was caused by the improvement in blood flow by NKCP(®). The use of dietary supplements based on the Japanese traditional food natto helps to relieve subjective symptoms for patients with lifestyle diseases receiving medical care.
authors: Department of Legal Medicine, Shiga University of Medical Science, Otsu, Shiga, Japan ; Department of Internal Medicine, Nagareyama Central Hospital, Nagareyama, Chiba, Japan.
authors: Masahito
authors: M
authors: Hitosugi
authors: Department of Internal Medicine, Nagareyama Central Hospital, Nagareyama, Chiba, Japan.
authors: Katsuo
authors: K
authors: Hamada
authors: Department of Internal Medicine, Nagareyama Central Hospital, Nagareyama, Chiba, Japan.
authors: Kazutaka
authors: K
authors: Misaka
keywords: Japanese traditional food; bacillopeptidase F; lifestyle disease; subjective symptom; supplement
references: Biochem Biophys Res Commun. 1993 Dec 30;197(3):1340-7
references: 8280151
references: J Cardiovasc Risk. 1996 Feb;3(1):69-75
references: 8783033
references: Eur J Vasc Endovasc Surg. 2009 Jun;37(6):661-70
references: 19328027
references: Blood Coagul Fibrinolysis. 2011 Jan;22(1):29-33
references: 20975532
references: Evid Based Complement Alternat Med. 2012;2012:125029
references: 22761635
references: J Nutr. 2008 Jun;138(6):1192S-8S
references: 18492856
references: Spine (Phila Pa 1976). 1995 Jan 1;20(1):11-9
references: 7709270
references: J Pharmacol Sci. 2005 Nov;99(3):247-51
references: 16258229
references: Circulation. 1993 Dec;88(6):2771-9
references: 8252690
references: Experientia. 1987 Oct 15;43(10 ):1110-1
references: 3478223
references: N Engl J Med. 2001 Feb 1;344(5):363-70
references: 11172169
references: Evid Based Complement Alternat Med. 2013;2013:978398
references: 23861720